07076
Castor Oil, Hydrogenated,Ethoxylated
Synonym(s):
Cremophor® RH 40, Macrogolglycerol hydroxystearate, PEG-40 castor oil, Polyoxyl 40 hydrogenated castor oil, RH 40
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Quality Level
impurities
≤0.2% sulfated ash (verfied on random samples only), ≤1 ppm ethylene oxide, ≤10 ppm dioxan, ≤10 ppm heavy metals (verfied on random samples only), ≤2 ppm arsenic (verfied on random samples only), ≤2.0% water, ≤5000 ppm acetic acid, ≤620 ppm diethylene glycol, ≤620 ppm ethylene glycol
ign. residue
≤0.25% (verfied onrandom samples only)
acid value
≤0.8 mg KOH/g
hydroxyl value
60‑75 mg KOH/g
iodine value
≤1.0 g I2/100 g
saponification value
50‑60 mg KOH/g
suitability
suitable for acidity or alkalinity
Application
Castor Oil, Hydrogenated,Ethoxylated is used to solubilize vitamins, water insoluble active substances and essential oils in water or mixtures of water and alcohol.
Analysis Note
congealing temperature 16-26°C
Other Notes
Castor Oil, Hydrogenated, Ethoxylated is the brand name for a range of non-ionic polyethoxylated detergents. It was developed for use as solubilizers and emulsifiers.
Legal Information
Cremophor is a registered trademark of BASF SE
Storage Class
11 - Combustible Solids
flash_point_f
467.6 °F
flash_point_c
242 °C
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Christofori M R R Nastiti et al.
Pharmaceutics, 12(2) (2020-02-06)
Resveratrol (RSV) is a potent lipophilic antioxidant with a low aqueous solubility. Novel nanoformulations have been successfully developed and evaluated to increase the potential of resveratrol as a skin targeting antioxidant. Nanoformulations were prepared using a spontaneous emulsification method, and
Allergic contact dermatitis to polyethylene glycol-7 hydrogenated castor oil.
M Kalavala et al.
Contact dermatitis, 56(5), 287-288 (2007-04-20)
William J Gradishar et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(31), 7794-7803 (2005-09-21)
ABI-007, the first biologically interactive albumin-bound paclitaxel in a nanameter particle, free of solvents, was compared with polyethylated castor oil-based standard paclitaxel in patients with metastatic breast cancer (MBC). This phase III study was performed to confirm preclinical studies demonstrating